Porphyria prevalence ranges from roughly 1 in 500 to 1 in 50,000 depending on type, and acute intermittent porphyria, the most common acute hepatic porphyria, affects about 1 in 100,000 Americans. Among patients with recurrent attacks, 65% report chronic symptoms and 46% experience daily symptoms, and symptomatic patients reach disability pension at a median age of about 45. Because acute attacks occur predominantly in women under 50 and become rare after menopause, primary care in the Medicare population manages accumulated organ injury rather than acute crises, making subtype-specific recognition and documentation among the highest-value clinical actions a care team can take.
AAVBC's Porphyria Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across acute hepatic and cutaneous porphyria subtypes, HCC/RAF V28 mapping, diagnostic thresholds aligned to AGA 2023 and IPNET 2026 guidance, MEAT documentation standards, AGA/IPNET-aligned therapy escalation, medication safety, comorbidity screening for chronic kidney disease and hepatocellular carcinoma, and referral and follow-up timing. Grounded in current AGA and IPNET guidance, this guide supports consistent, individualized clinical decision-making, helping care teams distinguish porphyria subtypes and document long-term organ injury completely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of porphyria — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Porphyria prevalence ranges from roughly 1 in 500 to 1 in 50,000 depending on type, and acute intermittent porphyria, the most common acute hepatic porphyria, affects about 1 in 100,000 Americans. Among patients with recurrent attacks, 65% report chronic symptoms and 46% experience daily symptoms, and symptomatic patients reach disability pension at a median age of about 45. Because acute attacks occur predominantly in women under 50 and become rare after menopause, primary care in the Medicare population manages accumulated organ injury rather than acute crises, making subtype-specific recognition and documentation among the highest-value clinical actions a care team can take.
AAVBC's Porphyria Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity across acute hepatic and cutaneous porphyria subtypes, HCC/RAF V28 mapping, diagnostic thresholds aligned to AGA 2023 and IPNET 2026 guidance, MEAT documentation standards, AGA/IPNET-aligned therapy escalation, medication safety, comorbidity screening for chronic kidney disease and hepatocellular carcinoma, and referral and follow-up timing. Grounded in current AGA and IPNET guidance, this guide supports consistent, individualized clinical decision-making, helping care teams distinguish porphyria subtypes and document long-term organ injury completely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of porphyria — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
